SUBSCRIBE
SUBSCRIBE
News   FDA

New Use For Cancer Fighter; Genentech, Inc. Says It Will Cap Price

October 13, 2006 | 
1 min read

Genentech said Wednesday that U.S. regulators approved its cancer drug Avastin in combination with chemotherapy to treat lung cancer. The company also said it would cap the annual cost of the drug to some patients. >>> Discuss This Story

FDA Approvals
Genentech, Inc. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
 · 
4 min read
 · 
Heather McKenzie
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
The court's decision cancels all agreements. Agreement between the parties to the dispute. Conflict resolution in court.
COVID-19
FDA Shoots Down Invivyd’s Bid to Expand EUA for COVID-19 Antibody
February 24, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Minimal Clip Art Collage. Pop Vector Design Composition with bright bold geometric shapes, halftone objects for ad, animation etc
Approvals
Mirum Establishes Liver Expertise With First FDA Nod for ‘Very Rare’ Disease
February 24, 2025
 · 
2 min read
 · 
Tristan Manalac